Compounds > ethoxyresorufin

ethoxyresorufin and phenacetin

ethoxyresorufin has been researched along with phenacetin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiba, K; Echizen, H; Ishizaki, T; Tani, M; Yoshimoto, K1
Angus, PW; Blake, CL; Ching, MS; Ghabrial, H; Malek, NA1
Goto, Y; Kamakura, S; Katoh, M; Kawai, M; Kimura, H; Kitakaze, M; Komamura, K; Minami, N; Murayama, N; Nakajima, Y; Ohnuma, T; Ohtsuki, T; Ozawa, S; Saito, Y; Saitoh, O; Sawada, J; Soyama, A; Sugai, K; Suzuki, C; Ueno, K1
Ahn, T; Jung, HC; Kim, D; Kim, DH; Pan, JG; Park, SH; Yun, CH1
Hirasawa, N; Hiratsuka, M; Ito, M; Katono, Y; Oda, A1
Brossette, T; Hollender, J; Jose, J; Maas, R; Quehl, P; Schüürmann, J1

Other Studies

6 other study(ies) available for ethoxyresorufin and phenacetin

ArticleYear
Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers--N-desisopropylation is mediated mainly by CYP1A2.
    British journal of clinical pharmacology, 1995, Volume: 39, Issue:4

    Topics: Aged; Benzoflavones; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Desipramine; Ditiocarb; Female; Humans; Hydroxylation; In Vitro Techniques; Isoenzymes; Male; Mephenytoin; Microsomes, Liver; Middle Aged; Oxazines; Phenacetin; Propranolol; Quinidine; Recombinant Proteins; Stereoisomerism; Substrate Specificity; Sulfaphenazole; Tolbutamide; Troleandomycin

1995
Differential inhibition of human CYP1A1 and CYP1A2 by quinidine and quinine.
    Xenobiotica; the fate of foreign compounds in biological systems, 2001, Volume: 31, Issue:11

    Topics: Acetaminophen; Animals; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Enzyme Inhibitors; Humans; Microsomes, Liver; Oxazines; Phenacetin; Quinidine; Quinine; Rats; Recombinant Proteins; Yeasts

2001
Six novel nonsynonymous CYP1A2 gene polymorphisms: catalytic activities of the naturally occurring variant enzymes.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 308, Issue:1

    Topics: Amino Acid Sequence; Animals; Cells, Cultured; Cricetinae; Cytochrome P-450 CYP1A2; Humans; Kinetics; Molecular Sequence Data; Mutagenesis, Site-Directed; Oxazines; Phenacetin; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Sequence Homology, Amino Acid; Substrate Specificity; Transfection

2004
Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:5

    Topics: Amino Acid Substitution; Bacterial Proteins; Biocatalysis; Carbon; Chlorzoxazone; Coumarins; Cytochrome P-450 Enzyme System; Enzyme Stability; Escherichia coli; Heme; Humans; Indigo Carmine; Indoles; Kinetics; Molecular Dynamics Simulation; NADPH-Ferrihemoprotein Reductase; Nitrophenols; Oxazines; Oxidation-Reduction; Phenacetin; Protein Engineering; Recombinant Proteins; Transformation, Genetic; Umbelliferones

2010
Functional characterization of 20 allelic variants of CYP1A2.
    Drug metabolism and pharmacokinetics, 2015, Volume: 30, Issue:3

    Topics: Alleles; Amino Acid Substitution; Animals; Blotting, Western; Chlorocebus aethiops; COS Cells; Cytochrome P-450 CYP1A2; Humans; Oxazines; Phenacetin; Polymorphism, Genetic; Substrate Specificity; Transfection

2015
Co-expression of active human cytochrome P450 1A2 and cytochrome P450 reductase on the cell surface of Escherichia coli.
    Microbial cell factories, 2016, Feb-02, Volume: 15

    Topics: Base Sequence; Biocatalysis; Cell Membrane; Culture Media; Cytochrome P-450 CYP1A2; Cytochromes c; Escherichia coli; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression; Genetic Vectors; Humans; Molecular Sequence Data; Oxazines; Peptide Hydrolases; Phenacetin; Substrate Specificity; Time Factors

2016